Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...

The Centers for Medicare and Medicaid Services proposed changes to reduce prescription drug costs for Medicare Advantage and ...

It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

The outgoing Biden administration is proposing to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare ...

Several obesity experts said perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications.

Some of what RFK Jr. says about obesity prevention isn't new. But after having coined the catchy MAHA acronym, it’s likely ...

While Ozempic bodes well for weight loss, some users are concerned the drug's impact also means unwanted changes to their ...

LANGHORNE, PA — Amplity Health shared valuable findings from its latest study on GLP-1 receptor agonist (GLP-1 RA) usage ...

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

For employers wanting to dip a toe into the GLP-1 medications pool, utilization management is recommended to control costs.

Insurers, including the state, might consider serving up exercise and cooking classes along with the prescription.

We recently published a list of 12 Best ADR Stocks To Invest In According to Analysts. In this article, we are going to take ...